Asmaa E. Kassab

1.2k total citations
56 papers, 1.0k citations indexed

About

Asmaa E. Kassab is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Asmaa E. Kassab has authored 56 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Organic Chemistry, 19 papers in Molecular Biology and 19 papers in Pharmacology. Recurrent topics in Asmaa E. Kassab's work include Synthesis and biological activity (38 papers), Synthesis and Characterization of Heterocyclic Compounds (14 papers) and Synthesis and Biological Evaluation (11 papers). Asmaa E. Kassab is often cited by papers focused on Synthesis and biological activity (38 papers), Synthesis and Characterization of Heterocyclic Compounds (14 papers) and Synthesis and Biological Evaluation (11 papers). Asmaa E. Kassab collaborates with scholars based in Egypt, Saudi Arabia and United States. Asmaa E. Kassab's co-authors include Ehab M. Gedawy, Afaf El‐Malah, Manal M. Kandeel, Rasha A. Hassan, Eman Ahmed, Ahmed M. El Kerdawy, Zeinab Mahmoud, Ahmed S. Doghish, Maha M. Abdel‐Fattah and Hanan M. Refaat and has published in prestigious journals such as RSC Advances, International Journal of Biological Macromolecules and European Journal of Medicinal Chemistry.

In The Last Decade

Asmaa E. Kassab

53 papers receiving 984 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Asmaa E. Kassab Egypt 16 691 391 180 102 100 56 1.0k
Laurence Goossens France 19 651 0.9× 579 1.5× 206 1.1× 44 0.4× 127 1.3× 50 1.2k
Velma Ganga Reddy India 18 871 1.3× 371 0.9× 100 0.6× 83 0.8× 151 1.5× 37 1.1k
Somaia S. Abd El‐Karim Egypt 19 922 1.3× 315 0.8× 166 0.9× 179 1.8× 163 1.6× 51 1.2k
Narsimha Reddy Penthala United States 21 578 0.8× 440 1.1× 155 0.9× 67 0.7× 99 1.0× 85 1.1k
Daulat Bikram Khadka South Korea 17 373 0.5× 352 0.9× 133 0.7× 35 0.3× 103 1.0× 34 879
Ehab M. Gedawy Egypt 14 405 0.6× 303 0.8× 87 0.5× 43 0.4× 89 0.9× 29 640
Xuewei Wu China 15 463 0.7× 693 1.8× 127 0.7× 84 0.8× 212 2.1× 28 1.3k
C. V. Kavitha India 19 660 1.0× 354 0.9× 78 0.4× 49 0.5× 99 1.0× 40 1.0k
B.T. Prabhakar India 22 480 0.7× 427 1.1× 98 0.5× 38 0.4× 193 1.9× 51 989
Phoebe F. Lamie Egypt 18 712 1.0× 201 0.5× 214 1.2× 127 1.2× 68 0.7× 33 875

Countries citing papers authored by Asmaa E. Kassab

Since Specialization
Citations

This map shows the geographic impact of Asmaa E. Kassab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asmaa E. Kassab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asmaa E. Kassab more than expected).

Fields of papers citing papers by Asmaa E. Kassab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asmaa E. Kassab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asmaa E. Kassab. The network helps show where Asmaa E. Kassab may publish in the future.

Co-authorship network of co-authors of Asmaa E. Kassab

This figure shows the co-authorship network connecting the top 25 collaborators of Asmaa E. Kassab. A scholar is included among the top collaborators of Asmaa E. Kassab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asmaa E. Kassab. Asmaa E. Kassab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ayoup, Mohammed Salah, Saied M. Soliman, Ibrahim Elghamry, et al.. (2025). Impact of trifluoromethyl Ugi adducts as anticancer agents: EGFR inhibition, apoptosis induction and miRNA up-regulation. RSC Advances. 15(24). 19530–19545. 1 indexed citations
2.
Kassab, Asmaa E.. (2025). Recent advances in targeting COX-2 for cancer therapy: a review. RSC Medicinal Chemistry. 16(7). 2974–3002. 3 indexed citations
3.
Kandeel, Manal M., et al.. (2024). Medicinal attributes of thienopyrimidine scaffolds incorporating the aryl urea motif as potential anticancer candidates via VEGFR inhibition. Archiv der Pharmazie. 357(8). e2400125–e2400125. 2 indexed citations
4.
Kassab, Asmaa E. & Ehab M. Gedawy. (2024). Repurposing of Indomethacin and Naproxen as anticancer agents: progress from 2017 to present. RSC Advances. 14(54). 40031–40057. 2 indexed citations
5.
Ayoup, Mohammed Salah, Hamida Abdel‐Hamid, Yasair S. Al‐Faiyz, et al.. (2024). Design, synthesis, and biological evaluation of 1,2,4-oxadiazole-based derivatives as multitarget anti-Alzheimer agents. RSC Medicinal Chemistry. 15(6). 2080–2097. 9 indexed citations
6.
Ayoup, Mohammed Salah, et al.. (2024). Novel Ag(I)‐based 1,2,4‐Oxadiazole Complexes: Synthesis, X‐Ray Crystal Structure, and Biological Evaluation as Anticancer Candidates. Applied Organometallic Chemistry. 39(2). 3 indexed citations
7.
Ayoup, Mohammed Salah, Hamida Abdel‐Hamid, Doaa A. Ghareeb, et al.. (2024). Novel sulfonamide derivatives as multitarget antidiabetic agents: design, synthesis, and biological evaluation. RSC Advances. 14(11). 7664–7675. 14 indexed citations
8.
Kassab, Asmaa E., et al.. (2024). Drug repurposing of fluoroquinolones as anticancer agents in 2023. RSC Advances. 14(50). 37114–37130. 2 indexed citations
9.
Kassab, Asmaa E., et al.. (2023). Topoisomerase II inhibitors design: Early studies and new perspectives. Bioorganic Chemistry. 136. 106548–106548. 41 indexed citations
10.
Kassab, Asmaa E.. (2023). Anticancer agents incorporating the N‐acylhydrazone scaffold: Progress from 2017 to present. Archiv der Pharmazie. 356(5). e2200548–e2200548. 14 indexed citations
11.
Kassab, Asmaa E.. (2023). Benzotriazole scaffold: An overview of antiproliferative potential, mechanisms of action, and structure–activity relationships. Archiv der Pharmazie. 356(8). e2300102–e2300102. 5 indexed citations
12.
Mohamed, Khaled O., et al.. (2023). New Phenylthiazoles: Design, Synthesis, and Biological Evaluation as Antibacterial, Antifungal, and Anti‐COVID‐19 Candidates. Chemistry & Biodiversity. 20(11). e202301143–e202301143. 6 indexed citations
13.
Kamel, Mona, et al.. (2023). Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease. Drug Development Research. 84(5). 937–961. 20 indexed citations
14.
Kamel, Mona, et al.. (2022). Design, synthesis, and biological evaluation of thienopyrimidine and thienotriazine derivatives as multitarget anti‐Alzheimer agents. Drug Development Research. 83(6). 1394–1407. 9 indexed citations
15.
Kassab, Asmaa E.. (2022). Pyrazolo[3,4‐d]pyrimidine scaffold: A review on synthetic approaches and EGFR and VEGFR inhibitory activities. Archiv der Pharmazie. 356(1). e2200424–e2200424. 14 indexed citations
16.
Kassab, Asmaa E., et al.. (2022). Design, synthesis, and biological evaluation of new celecoxib analogs as apoptosis inducers and cyclooxygenase‐2 inhibitors. Archiv der Pharmazie. 355(11). e2200190–e2200190. 10 indexed citations
17.
Kassab, Asmaa E., et al.. (2022). Recent advances in the development of celecoxib analogs as anticancer agents: A review. Archiv der Pharmazie. 355(12). e2200326–e2200326. 11 indexed citations
18.
Ahmed, Eman, et al.. (2022). Anti‐inflammatory activity of pyridazinones: A review. Archiv der Pharmazie. 355(8). e2200067–e2200067. 13 indexed citations
19.
Mahmoud, Zeinab, et al.. (2022). Recent green approaches for the synthesis of pyrazolo[3,4‐d]pyrimidines: A mini review. Archiv der Pharmazie. 355(6). e2100470–e2100470. 4 indexed citations
20.
Kamel, Mona, et al.. (2022). Development of new Alzheimer's disease drug candidates using donepezil as a key model. Archiv der Pharmazie. 356(1). e2200398–e2200398. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurence Goossens Breakdown of academic impact, for papers by Velma Ganga Reddy Breakdown of academic impact, for papers by Somaia S. Abd El‐Karim Breakdown of academic impact, for papers by Narsimha Reddy Penthala Breakdown of academic impact, for papers by Daulat Bikram Khadka Breakdown of academic impact, for papers by Ehab M. Gedawy Breakdown of academic impact, for papers by Xuewei Wu Breakdown of academic impact, for papers by C. V. Kavitha Breakdown of academic impact, for papers by B.T. Prabhakar Breakdown of academic impact, for papers by Phoebe F. Lamie
Rankless by CCL
2026